Results 91 to 100 of about 41,093 (226)

Mapping the Research Landscape of the Correlation Between Radiotherapy and Tumor Immune Microenvironment: A Bibliometric Analysis

Precision Radiation Oncology, EarlyView.
The first bibliometric analysis of 2,584 articles revealed studies led by China on radiotherapy and tumor immune microenvironment. The analysis concluded that the research in this field has gone through three stages: mechanism exploration, clinical validation, and technological and personalized optimization.
Shangyi Geng, Xia Li, Yongze Dang, Xinran Huang, Lintao Zhang, Xinyu He, Shupei Pan, Hongbing Ma, Xixi Zhao   +8 more
wiley   +1 more source

Epigenetic modification in radiotherapy and immunotherapy for cancers

Tzu Chi Medical Journal
Radiotherapy (RT) is one of the primary treatment modalities in managing cancer patients. Recently, combined RT and immunotherapy (IT) (i.e., radio-IT [RIT]) have been aggressively investigated in managing cancer patients.
Shih-Kai Hung, Moon-Sing Lee, Wen-Yen Chiou, Dai-Wei Liu, Chih-Chia Yu, Liang-Cheng Chen, Ru-Inn Lin, Chia-Hui Chew, Feng-Chun Hsu, Hsuan-Ju Yang, Michael W. Y. Chan, Hon-Yi Lin   +11 more
doaj   +1 more source

Developments in Stereotactic Body Radiotherapy [PDF]

Cancers, 2018
Stereotactic body radiotherapy is the technique of accurately delivering high doses of radiotherapy to small volume targets in a single or small number of sessions. The high biological effective dose of this treatment is reflected in the high rates of local control achieved across multiple tumour sites.
openaire   +2 more sources

Spatially fractionated radiotherapy versus conventional radiotherapy in the treatment of soft tissue sarcoma: A multicenter, prospective, phase II, randomized controlled clinical trial protocol

Precision Radiation Oncology, EarlyView.
The first randomized controlled trial comparing spatially fractionated radiotherapy (SFRT) with conventional radiotherapy (CRT) for soft tissue sarcoma (STS) will evaluate efficacy and safety, offering critical evidence to optimize treatment strategies.
Peng Shang, Minghao Li, Xiang Zhang, Dongyuan Zhu, Jinbo Yue   +4 more
wiley   +1 more source

Stereotactic radiotherapy in oligometastatic cancer

Chinese Clinical Oncology, 2017
Oligometastatic cancer describes a disease state somewhere between localized and metastatic cancer. Proposed definitions of oligometastatic disease have typically used a cut-off of five or fewer sites of disease. Treatment of oligometastatic disease should have the goal of long-term local control, and in selected cases, disease remission. While several
Thomas A C, Kennedy, Mark T, Corkum, Alexander V, Louie   +2 more
openaire   +2 more sources

A new perspective on cancer treatment: the interaction and application prospect between ICIs and radiotherapy

Precision Radiation Oncology, EarlyView.
The combination of immune checkpoint inhibitors (ICIs) and radiotherapy synergistically enhances efficacy through an “antigen release‐immune activation” closed‐loop mechanism, significantly improving outcomes in solid tumors (e.g., lung cancer, melanoma).
Guiling Song, Lei Wang, Guopeng Zhao, Song Tan, Xin Liu, Xinghua Li   +5 more
wiley   +1 more source

Stereotactic radiotherapy for wet age-related macular degeneration: current perspectives

Clinical Ophthalmology, 2015
James E Neffendorf, Timothy L Jackson Department of Ophthalmology, School of Medicine, King’s College London, London, United Kingdom Abstract: Neovascular age-related macular degeneration is a leading cause of blindness in the developed world ...
Neffendorf JE, Jackson TL
doaj  

Establishment and Comparative Analysis of Radiation‐Induced Liver Disease in Normal and Fibrotic Rat Models

Precision Radiation Oncology, EarlyView.
This study successfully established two novel rat models of radiation‐induced liver disease (RILD), one in healthy livers and the other in TAA‐induced fibrotic livers, providing valuable insights into the combined effects of radiation and pre‐existing fibrosis.
Yanting Jiang, Yuxi Ding, Fang Wang, Danni Chen, Weixiang Zhong, Zhongjie Lu, Yixiang J. Wang, Senxiang Yan, Xiaoguang Liu, Feng Zhao   +9 more
wiley   +1 more source

Thoracic radiotherapy may enhance the survival of patients with low‐risk advanced lung adenocarcinoma based on protein biomarkers

Precision Radiation Oncology, EarlyView.
The prognosis of LUAD was significantly influenced by many clinical and protein biomarkers. A risk model was developed to help identify advanced LUAD patients who would benefit from thoracic radiotherapy, and thoracic radiotherapy just significantly improved the survival of low‐risk patients but not that of high‐risk.
Chunliu Meng, Fang Wang, Juan Wang, Jia Tian, Xue Li, Haijun Lu, Lujun Zhao, Ping Wang   +7 more
wiley   +1 more source

A Feasibility Study of the Repurposing of Prazosin to Improve Treatment Outcomes in Men Receiving Radiotherapy for Prostate Cancer (MiniRaP‐00)

The Prostate, EarlyView.
ABSTRACT Background Further work is needed to improve treatment outcomes for prostate cancer (PCa), with the repurposing of the α1‐adrenoreceptor antagonists presenting a potential solution. This feasibility clinical trial presents the first prospective data of the use of an α1‐adrenoreceptor antagonist in men undergoing radiotherapy for PCa.
Liam D. King, David Christie, Daniel Cehic, Wendy Dare, Russ Chess‐Williams, Donna Sellers, Catherine McDermott, Alexandra McCarthy, Shailendra Anoopkumar‐Dukie   +8 more
wiley   +1 more source